Jaswinder Singh Khera
Algemeen Directeur bij WEP Clinical
Oorsprong van het eerstegraads netwerk van Jaswinder Singh Khera
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
WEP Group Holdings Ltd.
WEP Group Holdings Ltd. Medical DistributorsDistribution Services WEP Group Holdings Ltd. was founded in 2017 and is a British company that creates broader treatment access solutions for patients worldwide. The company is based in London, UK, and has subsidiaries in the United Kingdom. The company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them.
2
| Holding Company | Medical Distributors | 2 |
WEP Clinical
WEP Clinical Pharmaceuticals: MajorHealth Technology WEP Clinical is a specialist services company founded in 2008 that works with drug developers to help patients and physicians gain early access to medicines when no other treatment options are available. The private company is based in Morrisville, NC, and has offices located in the UK, Switzerland, and Ireland. The company possesses all the necessary licenses allowing them to meet drug access and distribution needs across all regions worldwide. The company also provides pharmacovigilance (PV) services and drug commercialization services to help pharmaceutical companies successfully commercialize products in different countries where the product has yet to be registered. The CEO of the company is Jaswinder Singh Khera.
1
| Private Company | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jaswinder Singh Khera via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
WE Pharma Ltd.
WE Pharma Ltd. Medical DistributorsDistribution Services Part of WEP Group Holdings Ltd., WE Pharma Ltd. creates broader treatment access solutions for patients worldwide. The company is based in London, UK. The British company works with companies to set up and manage expanded access programs (EAPs) and post-approval named patient programs (PA-NPPs). EAPs allow sponsors to supply investigational drugs to patients who cannot enroll in active studies, while PA-NPPs allow sponsors to provide approved drugs to patients who need them. | Medical Distributors | Director/Board Member Director/Board Member |
Statistieken
Internationaal
Verenigd Koninkrijk | 2 |
Sectoraal
Distribution Services | 2 |
Operationeel
Director/Board Member | 4 |
Corporate Secretary | 1 |
Chief Operating Officer | 1 |
Sterkste connecties
- Beurs
- Insiders
- Jaswinder Singh Khera
- Bedrijfsconnecties